Patients suffering from CAPS often show dramatic improvement upon IL-1β blockade using an IL-1β receptor antagonist (IL-Ra) [18], [20], which indicates an important role of this cytokine in the pathogenesis of these diseases. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.